Combination of lithium and duloxetine in 2 depressed patients refractory to duloxetine monotherapy

Pharmacopsychiatry

Volumn 44, Issue 2, 2011, Pages 72-74

  Steffenhagen, N ^a   Kurstein B ^a   Kirkby, K C ^b   Himmerich, H ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DESIPRAMINE; DOXEPIN; DULOXETINE; LITHIUM CARBONATE; MIRTAZAPINE; MOCLOBEMIDE; TRANYLCYPROMINE; TRIMIPRAMINE; VALPROIC ACID; VENLAFAXINE;

ADD ON THERAPY; ADJUVANT THERAPY; AGED; ANAMNESIS; CASE REPORT; DEPRESSION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; EPILEPSY; FALLING; FEMALE; HOSPITAL DISCHARGE; HUMAN; LETHARGY; LETTER; MALE; MENINGIOMA; NAUSEA; ORTHOSTATIC HYPOTENSION; ORTHOSTATIC INTOLERANCE; PRIORITY JOURNAL; RECURRENT DISEASE;

AGED; ANTIMANIC AGENTS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; LITHIUM CARBONATE; MALE; OUTPATIENTS; SEROTONIN UPTAKE INHIBITORS; THIOPHENES;

EID: 79953057792     PISSN: 01763679     EISSN: 14390795     Source Type: Journal    
DOI: 10.1055/s-0030-1268418     Document Type: Letter

References (17)

1. Dugan SE, Fuller MA. Duloxetine: a dual reuptake inhibitor. Ann Pharmacother 2004 38 2078-2085 (Pubitemid 40169380)
2. Girardi P, Pompili M, Innamorati M et al,. Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods. Hum Psychopharmacol 2009 24 177-190
3. Adli M, Bauer M, Rush AJ. Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review. Biol Psychiatry 2006 59 1029-1038 (Pubitemid 43849663)
4. Crossley NA, Bauer M. Acceleration and augmentation of antidepressants with lithium for depressive disorders: two meta-analyses of randomized, placebo-controlled trials. J Clin Psychiatry 2007 68 935-940 (Pubitemid 47015495)
5. Bschor T, Lewitzka U, Sasse J et al,. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms. Pharmacopsychiatry 2003 36 230-234
6. Fleurence R, Williamson R, Jing Y et al,. A systematic review of augmentation strategies for patients with major depressive disorder. Psychopharmacol Bull 2009 42 57-90
7. Baumann P, Nil R, Souche A et al,. A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation. J Clin Psychopharmacol 1996 16 307-314 (Pubitemid 26254882)
8. Katona CL, Abou-Saleh MT, Harrison DA et al,. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 1995 166 80-86
9. Ontiveros A, Fontaine R, Elie R. Refractory depression: the addition of lithium to fluoxetine or desipramine. Acta Psychiatr Scand 1991 83 188-192
10. Bertschy G, Ragama-Pardos E, Ait-Ameur A et al,. Lithium augmentation in venlafaxine non-responders: an open study. Eur Psychiatry 2003 18 314-317 (Pubitemid 37461924)
11. Yates WR, Wesner RB, Thompson R. Organic mood disorder: a valid psychiatry consultation diagnosis? J Affect Disord 1991 22 37-42
12. Frampton JE, Plosker GL. Duloxetine: a review of its use in the treatment of major depressive disorder. CNS Drugs 2007 21 581-609 (Pubitemid 46991960)
13. Papakostas GI. Managing partial response or nonresponse: switching, augmentation, and combination strategies for major depressive disorder. J Clin Psychiatry 2009 70 16-25
14. Hoencamp E, Haffmans J, Dijken WA et al,. Lithium augmentation of venlafaxine: an open-label trial. J Clin Psychopharmacol 2000 20 538-543
15. Adan-Manes J, Novalbos J, Lopez-Rodriguez R et al,. Lithium and venlafaxine interaction: a case of serotonin syndrome. J Clin Pharm Ther 2006 31 397-400 (Pubitemid 44060206)
16. Mekler G, Woggon B. A case of serotonin syndrome caused by venlafaxine and lithium. Pharmacopsychiatry 1997 30 272-273 (Pubitemid 28006082)
17. Waring WS. Management of lithium toxicity. Toxicol Rev 2006 25 221-230